190 Background: Germ-line mutations in tumor suppressor genes, BRCA1 and BRCA2, confer high risks of breast and ovarian ...
...BRCA2. However, women with a family history of breast cancer are at increased risk of developing breast cancer compared ...
...BRCA2 positivity.,Of 172 individuals, 12/34 (35%) had BRCA1 BART mutations, and 7/11 (64%) had BRCA2 BART mutations. Of ...
...BRCA2 and conditional probabilities of carrying BRCA1 (CondBRCA1) and BRCA2 (CondBRCA2) given a proband is carrier.,The ...
...BRCA2 mutation (BRCA2) has not been found to overrepresent in women with TNBC. We have performed a meta-analysis of thes...
...BRCA2 genes mutation, and then about their eligibility to genetic testing and objective risk as estimated by BRCApro mod...
...BRCA2), referred to the high risk clinic for screening and prevention advice. Prior to and following genetic testing, pa...
...BRCA2 mutation carriers (B1/2). Prophylactic oophorectomy (PO) has been shown to decrease breast cancer (BC) risk in B1/...
...BRCA2, FANCA, FANCD2, RAD51) were overexpressed in tumour.,Mesothelioma resistance to therapy is reflected in the gene p...
...BRCA2 (n=43) MMR (MLH1, MSH2 MSH6) (n=31) and CDKN2A (n=15) genes in comparison with population based control families (...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
